BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10456618)

  • 1. Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients.
    Kario K; Matsuo T; Hoshide S; Kobayashi H; Sakata T; Mizuno O; Mitsuhashi T; Ikeda U; Miyata T; Shimada K
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):269-76. PubMed ID: 10456618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
    Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
    Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients.
    Porreca E; Di Febbo C; Amore C; Di Castelnuovo A; Baccante G; Donati MB; Cuccurullo F; Iacoviello L
    Thromb Haemost; 2000 Nov; 84(5):789-93. PubMed ID: 11127857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simvastatin and extrinsic coagulation pathway in peritoneally dialyzed patients].
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
    Pol Arch Med Wewn; 2002 Jun; 107(6):519-24. PubMed ID: 12371384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin and fenofibrate on butyrylcholinesterase activity in the brain, plasma, and liver of normolipidemic and hyperlipidemic rats.
    Vukšić A; Lovrić J; Konjevoda P; Blažević N; Bilušić M; Bradamante V
    Arh Hig Rada Toksikol; 2019 Mar; 70(1):30-35. PubMed ID: 30956215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria.
    Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T; Shimada K
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):455-61. PubMed ID: 8630673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bezafibrate on hypercoagulability assessed by fluorogenic prothrombin time in hyperlipidemic patients with non-insulin-dependent diabetes mellitus.
    Yoshinari M; Yamamoto M; Waklsaka M; Iwase M; Takano K; Fujishlma M
    Thromb Res; 1997 Jun; 86(6):443-51. PubMed ID: 9219324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients.
    Porreca E; Di Febbo C; di Castelnuovo A; Baccante G; Amore C; Angelini A; Di Nisio M; Donati M; Cuccurullo F; Iacoviello L
    Atherosclerosis; 2002 Nov; 165(1):159-66. PubMed ID: 12208482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Skoura L; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    J Atheroscler Thromb; 2010 Dec; 17(12):1256-65. PubMed ID: 20885069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of simvastatin on apolipoprotein M in vivo and in vitro.
    Zhang X; Mao S; Luo G; Wei J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
    Lipids Health Dis; 2011 Jul; 10():112. PubMed ID: 21729290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic effects of simvastatin in subjects with impaired fasting glucose.
    Krysiak R; Gdula-Dymek A; Okopień B
    Pharmacol Rep; 2010; 62(6):1090-8. PubMed ID: 21273666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.
    Jonkers IJ; de Man FH; van Tilburg NH; van der Laarse A; Sandset PM; Smelt AH; Bertina RM
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):705-12. PubMed ID: 11734672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects.
    Marketou ME; Zacharis EA; Nikitovic D; Ganotakis ES; Parthenakis FI; Maliaraki N; Vardas PE
    Angiology; 2006; 57(2):211-8. PubMed ID: 16518530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
    Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of gemfibrozil upon the hypercoagulable state in dyslipidaemic patients with chronic renal failure.
    Irish AB; Thompson CH
    Nephrol Dial Transplant; 1996 Nov; 11(11):2223-8. PubMed ID: 8941582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation.
    Undas A; Brummel KE; Musial J; Mann KG; Szczeklik A
    Circulation; 2001 May; 103(18):2248-53. PubMed ID: 11342472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan and simvastatin inhibit platelet activation in hypertensive patients.
    Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
    J Thromb Thrombolysis; 2004 Dec; 18(3):177-85. PubMed ID: 15815879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.
    Szapary L; Horvath B; Marton Z; Alexy T; Kesmarky G; Habon T; Szots M; Koltai K; Juricskay I; Czopf J; Toth K
    CNS Drugs; 2004; 18(3):165-72. PubMed ID: 14871160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.